Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ Scribed by A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; B. Barin; A. McMichael; J. Weber; K. Legg; A. Babiker; P. Hayes; F. Gotch; C. Smith; L. Dally; L. Dorrell; I. Cebere; R. Kay; N. Winstone; S. Moore; N. Goonetilleke; P. Fast

• Book ID: 116963551
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 91 KB
• Volume: 29
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2011.02.029